Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.
Saved in:
| Title: | Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial. |
|---|---|
| Authors: | Llombart-Cussac A; Hospital Arnau de Vilanova, FISABIO, Valencia, Spain. antoniollombart@medsir.org.; Universidad Católica de Valencia, Valencia, Spain. antoniollombart@medsir.org.; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain. antoniollombart@medsir.org., Prat A; Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors Lab., Barcelona, Spain., Pérez-García JM; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; International Breast Cancer Center, Pangea Oncology, QuironSalud Group, Barcelona, Spain., Mateos J; IEC Barcelona, Barcelona, Spain., Pascual T; Hospital Clínic i Provincial de Barcelona, Barcelona, Spain., Escrivà-de-Romani S; Hospital Universitari Vall Hebrón. Vall d'Hebron Institute of Oncology, Barcelona, Spain., Stradella A; ICO L'Hospitalet, Barcelona, Spain., Ruiz-Borrego M; Hospital Virgen del Rocío, Seville, Spain., de Las Heras BB; HCU Valencia, INCLIVA, Universidad de Valencia (CIBERONC-ISCIII, Madrid), Valencia, Spain., Keyaerts M; Vrije Universiteit Brussel, Brussels, Belgium., Galvan P; Translational Genomics and Targeted Therapies in Solid Tumors Lab., Barcelona, Spain., Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors Lab., Barcelona, Spain., García-Mosquera JJ; Dr. Rosell Oncology Institute (IOR), Dexeus University Hospital, Pangaea Oncology, Quironsalud Group, Barcelona, Spain., Guiot T; Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Institute Jules Bordet, Brussels, Belgium., Gion M; Hospital Ramón y Cajal, Madrid, Spain., Sampayo-Cordero M; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Di Cosimo S; Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy., Pérez-Escuredo J; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., de Frutos MA; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain., Cortés J; Universidad Católica de Valencia, Valencia, Spain.; International Breast Cancer Center, Pangea Oncology, QuironSalud Group, Barcelona, Spain.; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain., Gebhart G; Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Institute Jules Bordet, Brussels, Belgium. |
| Source: | European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (9), pp. 2733-2743. Date of Electronic Publication: 2024 Apr 08. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38587643 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinicopathological and molecular predictors of [<superscript>18</superscript>F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Llombart-Cussac+A%22">Llombart-Cussac A</searchLink>; Hospital Arnau de Vilanova, FISABIO, Valencia, Spain. antoniollombart@medsir.org.; Universidad Católica de Valencia, Valencia, Spain. antoniollombart@medsir.org.; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain. antoniollombart@medsir.org.<br /><searchLink fieldCode="AU" term="%22Prat+A%22">Prat A</searchLink>; Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors Lab., Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-García+JM%22">Pérez-García JM</searchLink>; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; International Breast Cancer Center, Pangea Oncology, QuironSalud Group, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mateos+J%22">Mateos J</searchLink>; IEC Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Pascual+T%22">Pascual T</searchLink>; Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Escrivà-de-Romani+S%22">Escrivà-de-Romani S</searchLink>; Hospital Universitari Vall Hebrón. Vall d'Hebron Institute of Oncology, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Stradella+A%22">Stradella A</searchLink>; ICO L'Hospitalet, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ruiz-Borrego+M%22">Ruiz-Borrego M</searchLink>; Hospital Virgen del Rocío, Seville, Spain.<br /><searchLink fieldCode="AU" term="%22de+Las+Heras+BB%22">de Las Heras BB</searchLink>; HCU Valencia, INCLIVA, Universidad de Valencia (CIBERONC-ISCIII, Madrid), Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Keyaerts+M%22">Keyaerts M</searchLink>; Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Galvan+P%22">Galvan P</searchLink>; Translational Genomics and Targeted Therapies in Solid Tumors Lab., Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Brasó-Maristany+F%22">Brasó-Maristany F</searchLink>; Translational Genomics and Targeted Therapies in Solid Tumors Lab., Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22García-Mosquera+JJ%22">García-Mosquera JJ</searchLink>; Dr. Rosell Oncology Institute (IOR), Dexeus University Hospital, Pangaea Oncology, Quironsalud Group, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Guiot+T%22">Guiot T</searchLink>; Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Institute Jules Bordet, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Gion+M%22">Gion M</searchLink>; Hospital Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sampayo-Cordero+M%22">Sampayo-Cordero M</searchLink>; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Di+Cosimo+S%22">Di Cosimo S</searchLink>; Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Pérez-Escuredo+J%22">Pérez-Escuredo J</searchLink>; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22de+Frutos+MA%22">de Frutos MA</searchLink>; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Cortés+J%22">Cortés J</searchLink>; Universidad Católica de Valencia, Valencia, Spain.; International Breast Cancer Center, Pangea Oncology, QuironSalud Group, Barcelona, Spain.; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gebhart+G%22">Gebhart G</searchLink>; Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Institute Jules Bordet, Brussels, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101140988%22">European journal of nuclear medicine and molecular imaging</searchLink> [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (9), pp. 2733-2743. <i>Date of Electronic Publication: </i>2024 Apr 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Berlin%22">Springer-Verlag Berlin </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101140988 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1619-7089 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216197070%22">16197070 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Nucl Med Mol Imaging <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38587643 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00259-024-06683-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2733 Titles: – TitleFull: Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Llombart-Cussac A – PersonEntity: Name: NameFull: Prat A – PersonEntity: Name: NameFull: Pérez-García JM – PersonEntity: Name: NameFull: Mateos J – PersonEntity: Name: NameFull: Pascual T – PersonEntity: Name: NameFull: Escrivà-de-Romani S – PersonEntity: Name: NameFull: Stradella A – PersonEntity: Name: NameFull: Ruiz-Borrego M – PersonEntity: Name: NameFull: de Las Heras BB – PersonEntity: Name: NameFull: Keyaerts M – PersonEntity: Name: NameFull: Galvan P – PersonEntity: Name: NameFull: Brasó-Maristany F – PersonEntity: Name: NameFull: García-Mosquera JJ – PersonEntity: Name: NameFull: Guiot T – PersonEntity: Name: NameFull: Gion M – PersonEntity: Name: NameFull: Sampayo-Cordero M – PersonEntity: Name: NameFull: Di Cosimo S – PersonEntity: Name: NameFull: Pérez-Escuredo J – PersonEntity: Name: NameFull: de Frutos MA – PersonEntity: Name: NameFull: Cortés J – PersonEntity: Name: NameFull: Gebhart G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2024 Jul Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1619-7089 Numbering: – Type: volume Value: 51 – Type: issue Value: 9 Titles: – TitleFull: European journal of nuclear medicine and molecular imaging Type: main |
| ResultId | 1 |
